19 Oct 2020
Evidence counts: latest Renal Denervation data and the Onyx ONE month DAPT program
Sponsored by Medtronic
On this page you will find a selection of interviews regarding the latest data on renal denervation from TCT Connect 2020, as well as the latest complex sub-analyses from the Onyx ONE Month DAPT program. View a series of short interviews here below!
Latest complex sub-analyses from the Onyx ONE Month DAPT program
- Onyx ONE acute coronary syndromes (ACS) subanalysis
Presenter: Elvin Kedhi
An evaluation of the safety and efficieny of DAPT and Onyx ONE combination among the high bleeding risk (HBR) patient population.
- Onyx ONE Clear atrial fibrillation (AF) subanalysis
Presenter: Sanjeevan Pasupati
- A comparison of atrial fibrillation (AF) and non AF patients after one month DAPT with Resolute Onyx DES.
- Onyx ONE Clear complex PCI subanalysis
Presenter: David Kandzari
- Evaluating lesion complexity in high bleeding Risk (HBR) patients treated for one month with DAPT.
See the data from the Onyx ONE Month DAPT Program
Latest data on renal denervation from TCT Connect 2020
- Patients with resistant hypertension in the Global SYMPLICITY registry
Presenter: Markus Schlaich
- This registry documented the effects of renal denervation (RDN) on blood pressure in patients with hypertension.
- Nerve Injury & Regrowth after RDN in Swine Model
- Micro dissection of human renal nervous system
Presenter: Andrew Sharp
- The histological observations of neuro degenerative changes after RDN with radio frequency (RF) using the Spyral catheter
- Renal anatomy findings from microdissection of a large sample of human cadavers
See More Data on Renal Denervation at Medtronic.com/RDN
Page published on 19 October 2020
With an unrestricted educational grant from Medtronic
